Table 3.
Exosome origin | Diseases | MicroRNA | Downstream molecular/pathways | MicroRNA methodology |
Placenta-derived mesenchymal stromal cells | Duchenne muscular dystrophy | MiR-29c | TGF-β | Reporter gene assays[106] |
Induced pluripotent stem cells | Group 2 innate lymphoid cell-dominant allergic airway | MiR-146a-5p | T helper 2 (Th2) cytokines | Anion-exchange chromatography; RNA sequencing[105] |
Mouse BM-MSCs | Peripheral neuropathy in diabetes | MiR-17, miR-23a, and miR-125b | TLR4/NF-κB signaling pathway. | MiRNA array; ultracentrifugation[164] |
MSCs | Myocardial ischemia-reperfusion injury | MiR-182 | TLR4 pathway | Differential centrifugation; miRNA sequencing[107] |
Human UC-MSCs | Burn-induced excessive inflammation | MiR-181c | TLR4 pathway | PureExo Column; miRNA array analysis[164] |
LPS-preconditioned MSCs | Wound healing | Let-7b | TLR4 pathway | Gradient centrifugation; miRNA microarray[111] |
Human UC-MSCs | Hyperglycemia-induced retinal inflammation | MiR-126 | HMGB1 signaling pathway | Ultracentrifugation[165] |
BM-MSCs: Bone marrow MSCs; UC-MSCs: Umbilical cord mesenchymal stem cells; MSCs: Mesenchymal stem cells; TGF-β: Transforming growth factor-β; TLR4: Toll-like receptor 4; HMGB1: High-mobility group box-1.